RxDoctor Payments Data

Jeffrey Gottfried, DO

Family Medicine · Fort Pierce, FLNPI 1639255516

Payments from drug & device makers

$1,549in general payments, 2019–2025

Across 80 payments — averaging $19.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$309
  • Amgen$223
  • AstraZeneca$200
  • Lilly USA, LLC$196
  • AbbVie$148
  • Exact Sciences$103
  • plus $370 from 8 others

What the payments were for

  • Food & beverage$1,50597%
  • Other$443%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,549 in reported general payments places this provider in the 70th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$61,032
Medicare patients
206
Services billed
535

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide137$186,008
MounjaroTirzepatide135$179,043
FarxigaDapagliflozin Propanediol83$82,998
EliquisApixaban56$53,613
Trelegy ElliptaFluticasone/Umeclidin/Vilanter34$36,627
JardianceEmpagliflozin23$30,745
VascepaIcosapent Ethyl39$29,977
Repatha PushtronexEvolocumab31$27,924
ProliaDenosumab12$21,179
XareltoRivaroxaban17$20,169
SymbicortBudesonide/Formoterol Fumarate36$15,320
Repatha SureclickEvolocumab21$14,792
Rosuvastatin Calcium666$10,501
Stiolto RespimatTiotropium Br/Olodaterol Hcl18$9,368
Ezetimibe289$6,421

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$309$186,008137 claims
Lilly USA, LLCMounjaro$196$179,043135 claims
AstraZenecaFarxiga, Symbicort$200$98,318119 claims
PfizerEliquis$51$53,61356 claims
GSKTrelegy Ellipta$59$36,62734 claims
AmgenProlia$223$21,17912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Fort Pierce

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →